MedTrace Logo

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

NCT00398177 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9999

Last updated 2025-12-24

No results posted yet for this study

Summary

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Conditions

  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease

Sponsors & Collaborators

  • The Leukemia and Lymphoma Society

    collaborator OTHER

  • Biospect Inc

    collaborator INDUSTRY

  • Stanford University

    lead OTHER

Principal Investigators

  • Ronald Levy, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-31
Primary Completion
2099-01-31
Completion
2099-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00398177 on ClinicalTrials.gov